Pretreatment Count of Peripheral Neutrophils, Monocytes, and Lymphocytes as Independent Prognostic Factor in Patients With Head and Neck Cancer
Usefulness of Lymphocyte-to-Monocyte, Neutrophil-to-Monocyte and Neutrophil-to-Lymphocyte Ratios as Prognostic Markers in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
Association Between Monocyte-to-Lymphocyte Ratio and Prostate Cancer in the U.S. Population: A Population-Based Study